DHC — Q2 2026 Financial Report Analysis

Diversified Healthcare Trust (DHC), a real estate investment trust (REIT) that owns senior housing and medical office buildings, cut its quarterly net loss to $37.4 million ($0.16 per share) in Q2 2026, from $91.6 million ($0.38) a year earlier. Total revenue still fell 4.5% to $365.4 million because DHC has sold dozens of properties since last year. The real change is in the senior housing it owns and pays outside companies to run: at communities owned in both periods, revenue rose 6.6% while operating costs rose only 1.9%, so property-level profit jumped 37.2%. Normalized FFO, the cash-earnings measure REITs use instead of net income, doubled to $0.16 per share.

At a glance

• Same-property senior housing NOI up 37.2% to $52.0 million. NOI (net operating income) is what the buildings earn after their direct running costs. Fuller communities (83.1% occupied vs 81.5%) paying higher monthly rates ($5,715 vs $5,380) explain it.
• Normalized FFO of $38.9 million, or $0.16 per share, vs $18.6 million ($0.08). About half the jump comes from lower interest costs after DHC refinanced its 2025–2026 debt, not only from the buildings.
• Net debt is 7.1x annualized adjusted EBITDAre, down from 8.7x a year ago. That is still high for a REIT. Moody's upgraded DHC's credit rating from Caa1 to B3 in April, but the rating remains deep in junk territory.

The numbers

Two terms are central here. FFO (funds from operations) starts from net income and adds back depreciation, which is a large non-cash charge on buildings, and gains or losses on property sales and impairments. Normalized FFO also strips out items DHC treats as one-offs or timing effects. SHOP stands for "senior housing operating portfolio": communities where DHC keeps the profit or loss of running them and pays a manager a fee, instead of collecting fixed rent from a tenant.

Senior housing is driving the turnaround

SHOP produced 63% of DHC's NOI this quarter. The filing gives the reasons directly. Same-property revenue rose "primarily due to increases in occupancy and average monthly rate at our communities." Expenses rose "primarily due to increases in labor costs, management fees as a result of higher revenues and insurance costs, partially offset by decreases in maintenance and repair expense, dietary expense and other direct costs."

Because senior housing has high fixed costs, each extra occupied unit adds a large share of its revenue to profit. That is why a 6.6% rise in revenue became a 37.2% rise in NOI. The same-property margin reached 17.3%, up 240 bps from Q1 and 390 bps from a year earlier.

Reported SHOP revenue still fell 2.9% to $317.9 million because DHC now owns 199 communities, down from 230. The 15 communities outside the same-property pool produced $16.7 million of revenue, against $45.1 million a year ago. They were also loss-making last year (NOI of -$1.3 million), so selling them helped margins even though it reduced revenue.

This is also the first full stretch since DHC moved 116 communities away from Five Star Senior Living, part of its affiliate AlerisLife, to seven other managers between September and December 2025. The quarter carried $3.1 million of transition costs related to that move.

Medical office and life science: smaller and flat

Revenue from medical office and life science buildings fell 16.5% to $40.1 million. DHC sold enough of these properties to cut the segment from 92 buildings to 67, and from 7.4 million to 5.6 million square feet. On a same-property basis, NOI was flat (-0.1%) at $24.1 million, and was down 1.3% on a cash basis. Rent rose only 0.5% from "net leasing activity," while real estate taxes and cleaning costs rose 1.5%.

Leasing was healthier than the NOI figure suggests. DHC signed about 477,000 sq ft of leases at rents 6.7% above the previous rents, with an average term of 7.1 years. Same-property occupancy is 95.8%. The segment is stable, but it is not adding growth.

What the headline numbers hide

• Last year's loss was inflated by one-offs. Q2 2025 included a $31.0 million impairment (a write-down of property values), a $7.4 million loss on property sales and $16.3 million of non-cash interest charges on notes due 2026 that DHC has since repaid. None of these recurred. Interest expense fell $13.8 million to $37.1 million, even after DHC added $375 million of 7.25% secured notes due 2030 and new mortgage loans.
• The gap between GAAP and Normalized FFO this quarter is mostly a fee to DHC's manager. GAAP general and administrative expense rose 73% to $19.3 million. The main cause is a $10.0 million accrual for the incentive fee owed to The RMR Group (vs $4.1 million a year ago), which is triggered because DHC's shareholder return beat a healthcare REIT index. Normalized FFO leaves this fee out until Q4, when the full-year amount is fixed. It is a real cash cost: DHC paid RMR $17.9 million in January 2026 for 2025. Year-to-date accruals are already $16.6 million, so expect Q4 normalized FFO to absorb a charge of that size if the stock holds up.
• Cash flow does not yet cover capital spending. First-half cash from operations was $46.7 million, below normalized FFO of $72.0 million. The January incentive-fee payment and the manager-transition costs account for much of the difference. Spending on building improvements was $59.4 million, more than operating cash flow. The gap was covered by a one-time $27.2 million final dividend from AlerisLife as it wound down, plus cash on hand. Full-year guidance calls for $100–115 million of recurring capital spending.
• The dividend is symbolic. At $0.01 per quarter (about $2.4 million), it uses 6.3% of normalized FFO. Its safety is not the question. The question is whether DHC eventually earns enough to pay a meaningful one.
• Leverage and maturities. Debt principal is $2.44 billion against $116.8 million of cash and an undrawn $150 million credit line. Only $2.9 million of scheduled principal payments are due in the rest of 2026 and 2027. The next ones are a $140 million floating-rate mortgage in March 2028, which has extension options, and $500 million of 4.75% unsecured notes due 2028. Adjusted EBITDAre covers interest 2.2 times.

Guidance

On June 1, DHC raised the midpoints of its 2026 guidance for SHOP NOI, adjusted EBITDAre and Normalized FFO by $10 million each, and it reaffirmed that guidance with the Q2 results. The current ranges are SHOP NOI of $185–195 million and Normalized FFO of $135–150 million, or $0.56–0.62 per share. That compares with Normalized FFO of $64.4 million in 2025, a year weighed down by $63.2 million of non-cash interest charges on the 2026 notes.

The assumptions behind the guidance shifted, though. DHC now expects same-property SHOP occupancy to grow about 200 bps for the year, 100 bps less than before, and revenue to grow about 6.6%, down from about 8.0%. Lower expected cost growth, about 2.5% instead of 4.5%, offsets the change. In other words, the profit target held because DHC expects lower costs, not because demand improved more than planned.

Takeaway: The senior housing turnaround is real at the property level: the same communities earned 37% more NOI on 160 bps more occupancy and 6% higher rates. But the year's profit target now depends more on cost control than on filling rooms, because DHC reduced its occupancy-growth assumption by a third while keeping NOI guidance unchanged.

Outlook

The first half delivered $97.1 million of SHOP NOI and $72.0 million of Normalized FFO. Reaching the guidance midpoints therefore requires only about $93 million and $70.5 million in the second half, below the run rate of Q2 alone. That makes the guidance look conservative, unless management expects higher costs in the winter months or a weaker Q4 once the incentive fee is booked.

Three things to watch in the Q3 report, expected in early November:

• whether same-property SHOP occupancy keeps rising from 83.1%, given the lower full-year occupancy assumption
• whether expense growth stays near 2% as labor and insurance costs move
• whether net debt to EBITDAre keeps falling toward the 6x range, which would make refinancing the 2028 maturities easier